DNase I functional microgels for neutrophil extracellular trap disruption. (23rd November 2021)

• Record Type: Journal Article
• Authors: Hosseinnejad, Aisa; Ludwig, Nadine; Wienkamp, Ann-Katrin; Rimal, Rahul; Bleilevens, Christian; Rossaint, Rolf; Rossaint, Jan; Singh, Smriti
• Is Part Of: Biomaterials science. Volume 10:Number 1(2022)
• Page Start: 85
• Page End: 99
• Publication Date: 2021-11-23
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d1bm01591e
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : Non-fouling DNase I conjugated microgel provide a novel biohybrid platform to disrupt Neutrophil extracellular traps (NETs) and can be used as a non-thrombogenic coating for reduction of NET-mediated inflammation and microthrombi formation. Abstract : Neutrophil extracellular traps (NETs) are web-like chromatin structures produced and liberated by neutrophils under inflammatory conditions which also promote the activation of the coagulation cascade and thrombus formation. The formation of NETs is quite prominent when blood comes in contact with artificial surfaces like extracorporeal circuits, oxygenator membranes, or intravascular grafts. DNase I as a factor of the host defense system, digests the DNA backbone of NETs, which points out its treatment potential for NET-mediated thrombosis. However, the low serum stability of DNase I restricts its clinical/therapeutic applications. To improve the bioavailability of the enzyme, DNase I was conjugated to the microgels (DNase I MG) synthesized from highly hydrophilic N -(2-hydroxypropyl) methacrylamide (HPMA) and zwitterionic carboxybetaine methacrylamide (CBMAA). The enzyme was successfully conjugated to the microgels without any alternation to its secondary structure. The K m value representing the enzymatic activity of the conjugated DNase I was calculated to be 0.063 μM demonstrating a high enzyme–substrate affinity. The DNase I MGs were protein repellant and were able to digest NETs more efficiently compared to free DNase in a biological media, remarkably even after long-term exposure to the stimulated neutrophils continuously releasing NETs. Overall, the conjugation of DNase I to a non-fouling microgel provides a novel biohybrid platform that can be exploited as non-thrombogenic active microgel-based coatings for blood-contacting surfaces to reduce the NET-mediated inflammation and microthrombi formation.